Metamizole Sodium, Solution for Injection, 500 Tender - 151406713

Procurement Summary

Country: Ukraine

Summary: Metamizole Sodium, Solution for Injection, 500 Mg/Ml, 2 Ml; Activated Charcoal Tablets/Capsules of 250 Mg Each; Acetylsalicylic Acid Tablets of 500 Mg; Diphenhydramine, Solution for Injection, 10 Mg/Ml, 1 M...

Deadline: 28 Oct 2026

Posting Date: 24 Oct 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151406713

Document Ref. No.: UA-2026-10-22-005822-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 16822.43

CPV Classification

33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs
33670000 - Medicinal products for the respiratory system
33640000 - Medicinal products for the genitourinary system and hormones
33610000 - Medicinal products for the alimentary tract and metabolism
33630000 - Medicinal products for dermatology and the musculo-skeletal system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Activated charcoal tablets/capsules of 250 mg each; Acetylsalicylic acid tablets of 500 mg; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Dexamethasone, solution for injection 4mg/ml; Drotaverin, solution for injection, 20 mg/ml, 2 ml each; Diclofenac solution for injection 25 mg/ml; Glucose solution for injections 40% in 20 ml; Glucose solution for infusions 5% in 200 ml (glass); Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Chloropyramine (Suprastin), solution for injection, 20 mg/ml, po 1 ml; Captopril, tablets, 25 mg each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Corglycon solution for injection, 0.6 mg/ml, 1 ml each; Ceftriaxone, powder for injections of 1 g; Ondansetron solution for injection 2 mg/ml in 4 ml; Caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; Ammonia, solution for external use, 10%, 40 ml each; Procaine solution for injection 5 mg/ml in ampoule 5 ml; Validol tablets 60 mg each; Loratadine 10 mg tablets; Chlorhexidine, solution for external use 0.05% per 100 ml according to DK 021:2015:33660000-4 Medicinal products for the treatment of nervous diseases system and diseases of sense organs
Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Acetylsalicylic acid tablets of 500 mg Acetylsalicylic acid, N02BA01, B01AC06, Tablets, Enteric-coated tablets, Effervescent tablets, 500 mg, Contour blister pack, Strip, Blister, Vial; Glucose solutions: Classification according to INN: Glucose, Dose of active substance: 50 mg/ml, Release form: Solution for infusion, Volume: 200, Type of packaging: Vial, Bottle, Classification according to ATX: B05CX01; Ondansetron solution for injection 2 mg/ml 4 ml; Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Packaging type: Vial NameClassifier and its corresponding codeQuantity/Units of measurementPlace of deliveryDate of deliveryName
DK 021:2015: 33600000-6 — Pharmaceutical products Acetylsalicylic acid tablets of 500 mg Acetylsalicylic acid, N02BA01, B01AC06, Tablets, Enteric-coated tablets, Effervescent tablets, 500 mg, Contour blister packaging, Strip, Blister, Vial; Glucose solutions: Classification according to INN: Glucose, Dose active substance: 50 mg/ml, Release form: Solution for infusion, Volume: 200, Packaging type: Vial, Bottle, Classification according to ATX: B05CX01; Ondansetron solution for injection 2 mg/ml in 4 ml; Classification according to ATC: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose active ingredient: 0.05%, Volume: 10...

Documents

 Tender Notice